SBIO

Alps Medical Breakthroughs

-$35.1M

Net Activity

Institutions Holding

59

Popularity Rank

#5596

Avg Weight

0.03%

Total Value

$43.7M

Ownership Trend

59 institutions currently hold SBIO, with 29 net buyers and 22 net sellers this quarter.

Institutional Moves

Institutional Moves (Q1 2026)

Neutral

Based on recent trading activity

Net Selling Institutions

22

Net Buying Institutions

29

Key Holders

View all 59 holding institutions

Quarterly Activity

Recent Activity

+$32.6M

Total Buy Value

$61.0M

Total Sell Value

New buy12
Trim14
Add17
Sold out8

29

Net Buyers

22

Net Sellers

Insider Trading (Form 4)

Form 144 Pre-Sale Notices

No Form 144 planned sale filings in the last 90 days

Beneficial Ownership (13D/13G)

No Schedule 13D/13G filings for this ticker

Material Events (8-K)

No Form 8-K filings for this ticker

FAQ

Who are the top institutional investors holding ALPS MEDICAL BREAKTHROUGHS (SBIO)?
Major stakeholders currently include Bank Of America CORP /de/ ($5.2M), Wells Fargo & Company/mn ($3.2M), Susquehanna International Group, LLP ($3.2M). Based on the latest 13F filings, there are a total of 59 tracked investment funds and institutions maintaining positions in SBIO.
What is the overall institutional sentiment toward SBIO recently?
Institutional sentiment appears Bearish (Net Selling). During the most recent reporting quarter, the stock experienced a net outflow of $35.1M, driven by 29 managers accumulating shares while 22 reduced their exposure.
Which institutions have been selling or reducing their SBIO positions?
In the latest period, 14 funds trimmed their holdings, and 8 managers completely exited their positions. The aggregate reported sell value was $61.0M.
Are there any notable investors adding SBIO to their portfolios?
Yes, buying activity remains notable. 12 institutions opened new positions in {ticker}, and 17 existing holders added to their shares. The total reported buy value for the quarter amounted to $32.6M.

Related Stocks